Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

87.67 +1.17 (+1.35%)
Streaming Delayed Price Updated: 11:50 AM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 776,279
Open 86.68
Bid (Size) 87.65 (3)
Ask (Size) 87.67 (1)
Prev. Close 86.50
Today's Range 86.50 - 88.50
52wk Range 60.57 - 95.73
Shares Outstanding 602,400,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
P/E Ratio Insights for Edwards Lifesciences
Via Benzinga

Performance

YTD
+16.01%
+16.01%
1 Month
-3.55%
-3.55%
3 Month
+0.82%
+0.82%
6 Month
+16.64%
+16.64%
1 Year
-4.08%
-4.08%

More News

Read More
$1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today
Via Benzinga
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Acquire Innovalve
From Edwards Lifesciences Corporation
Via Business Wire
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
Via Benzinga
The Analyst Landscape: 13 Takes On Edwards Lifesciences
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,900 Today
Via Benzinga
What Analysts Are Saying About Edwards Lifesciences Stock
Via Benzinga
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
From Edwards Lifesciences Corporation
Via Business Wire
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details
Via Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
Assessing Edwards Lifesciences: Insights From 11 Financial Analysts
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $16,000 Today
Via Benzinga
Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
Via Investor's Business Daily
Edwards Lifesciences to Sell Critical Care to BD
From Edwards Lifesciences Corporation
Via Business Wire
Here's How Much $1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
Via Benzinga
Indian Rival Meril Accuses Edwards Lifesciences Of Anti-Competitive Behavior In EU Antitrust Complaint
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Is It Time To Get Defensive With Healthcare Stocks?
Via Talk Markets
Jim Cramer: These Airline Stocks 'Trade Wildly,' Edwards Lifesciences 'At The Right Level To Buy'
Via Benzinga
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Via Investor's Business Daily
EW Stock Earnings: Edwards Lifesciences Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.